Radiotherapy for indolent lymphomas: how much is enough?

[1]  A. Ng,et al.  Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. , 2014, International journal of radiation oncology, biology, physics.

[2]  P. Hoskin,et al.  4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[3]  Marianne C Aznar,et al.  Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma. , 2014, International journal of radiation oncology, biology, physics.

[4]  D. de Jong,et al.  Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features , 2013, Haematologica.

[5]  P. Hoskin,et al.  Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  A. Horwich,et al.  Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. , 2008, Clinical lymphoma & myeloma.

[7]  H. Bartelink,et al.  Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. , 2005, European journal of cancer.

[8]  A. Hart,et al.  High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.